Iqbal Rabia, Bazaz Aemen Shafqat, Bajwa Ahmad Taimoor, Linn Hnin Nadi, Htet Nyan Linn, Marowa Sabrin, Ullah Asmat
Department of Internal Medicine, The Brooklyn Hospital Center, New York, NY, USA.
Rawalpindi Medical University, Rawalpindi, Pakistan.
Radiol Case Rep. 2024 Nov 22;20(2):909-915. doi: 10.1016/j.radcr.2024.10.109. eCollection 2025 Feb.
Polycythemia vera (PV) is a chronic myeloproliferative disorder characterized by increased red blood cell mass, leading to a heightened risk for thrombosis and hemorrhage. While thrombotic complications such as stroke, deep vein thrombosis, and pulmonary embolism are commonly associated with PV, coronary artery syndromes, as the initial presentation, are rare. Here, we present the case of a 73-year-old male who presented with severe chest pain and was diagnosed with non-ST-elevation myocardial infarction (NSTEMI). During his hospitalization, the patient experienced spontaneous psoas muscle hemorrhage, which prompted further investigation. Laboratory workup revealed elevated hemoglobin levels and a positive JAK2 V617F mutation, confirming a diagnosis of polycythemia vera. This case highlights the importance of considering myeloproliferative disorders in patients with atypical thrombotic and hemorrhagic events. It emphasizes the need for early diagnosis and appropriate treatment to optimize patient outcomes.
真性红细胞增多症(PV)是一种慢性骨髓增殖性疾病,其特征为红细胞量增加,导致血栓形成和出血风险升高。虽然诸如中风、深静脉血栓形成和肺栓塞等血栓性并发症通常与PV相关,但冠状动脉综合征作为首发表现却很罕见。在此,我们报告一例73岁男性患者,该患者因严重胸痛就诊,被诊断为非ST段抬高型心肌梗死(NSTEMI)。在住院期间,患者发生自发性腰大肌出血,这促使进一步检查。实验室检查发现血红蛋白水平升高以及JAK2 V617F突变阳性,确诊为真性红细胞增多症。该病例凸显了在患有非典型血栓形成和出血事件的患者中考虑骨髓增殖性疾病的重要性。它强调了早期诊断和适当治疗以优化患者预后的必要性。